Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal

BSE3072.8060.65 (+2.01 %)

PREV CLOSE ( ) 3012.15

OPEN PRICE ( ) 3057.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8027

TODAY'S LOW / HIGH ( )2981.00 3087.00

52 WK LOW / HIGH ( )2335 3314.8

NSE3074.9057.7 (+1.91 %)

PREV CLOSE( ) 3017.20

OPEN PRICE ( ) 3040.80

BID PRICE (QTY) 3074.90 (805)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 182466

TODAY'S LOW / HIGH( ) 2982.00 3089.20

52 WK LOW / HIGH ( )2329.9 3314.9

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

14216.4

13748.4

13537.3

13026.5

Total Expenditure

10882.3

9926

10259

9513

PBIDT (Excl OI)

3334.1

3822.4

3278.3

3513.5

Other Income

614.3

249.7

593.4

263.3

Operating Profit

3948.4

4072.1

3871.7

3776.8

Interest

23.6

33.9

52.6

Exceptional Items

PBDT

3924.8

4021.1

3837.8

3724.2

Depreciation

453.7

435.1

429.7

412.9

Profit Before Tax

3471.1

3586

3408.1

3311.3

Tax

804.1

848.3

806.2

757.9

Provisions and contingencies

Profit After Tax

2667

2737.7

2601.9

2553.4

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2667

2737.7

2601.9

2553.4

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2667

2737.7

2601.9

2553.4

Equity Capital

250.7

Face Value (IN RS)

Reserves

Calculated EPS

21.27

21.84

20.75

20.37

Calculated EPS (Annualised)

85.10

87.36

83.02

81.48

No of Public Share Holdings

42171847

42148322

% of Public Share Holdings

33.75

33.74

PBIDTM% (Excl OI)

23.45

27.80

24.21

26.97

PBIDTM%

27.77

29.61

28.60

28.99

PBDTM%

27.60

29.24

28.34

28.58

PBTM%

24.41

26.08

25.17

25.41

PATM%

18.76

19.91

19.22

19.60

Notes

Risk Disclosures on Derivatives

Quarterly Results

AJANTA PHARMA LTD.